Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
First Claim
1. An implantable osmotic pump system for delivering a pharmaceutical agent to a patient, comprising:
- an implantable pump, including;
a pump housing;
a moveable partition disposed within the housing, the partition dividing the housing into an osmotic driving compartment having an open end and a pharmaceutical agent compartment having a delivery orifice;
a first semi permeable membrane disposed in the open end of the osmotic driving compartment, the first semi permeable membrane being exposed to the patient;
a second semi permeable membrane disposed in the open end of the osmotic driving compartment, and a first impermeable barrier disposed over the second semi permeable membrane, the second semi permeable membrane being sealed from the patient until the first barrier is breached, wherein breaching the first barrier increases the surface area of semi permeable membrane exposed to the patient and increases a delivery rate of a pharmaceutical agent through the delivery orifice.
1 Assignment
0 Petitions
Accused Products
Abstract
Implantable devices and osmotic pump and catheter systems for delivering a pharmaceutical agent to a patient at selectable rates include an impermeable pump housing and a moveable partition disposed within the housing, the partition dividing the housing into an osmotic driving compartment having an open end and a pharmaceutical agent compartment having a delivery orifice. A plurality of semi permeable membranes may be disposed in the open end of the osmotic driving compartment and a number of impermeable barriers may seal selected ones of the plurality of semi permeable membranes from the patient until breached. Breaching one or more of the impermeable barriers increases the surface area of semi permeable membrane exposed to the patient and controllably increases the delivery rate of the pharmaceutical agent through the delivery orifice and catheter. Each of the plurality of semi permeable membranes may have a selected surface area, composition and/or thickness, to allow a fine-grained control over the infusion rate while the pump is implanted in the patient.
130 Citations
32 Claims
-
1. An implantable osmotic pump system for delivering a pharmaceutical agent to a patient, comprising:
-
an implantable pump, including;
a pump housing;
a moveable partition disposed within the housing, the partition dividing the housing into an osmotic driving compartment having an open end and a pharmaceutical agent compartment having a delivery orifice;
a first semi permeable membrane disposed in the open end of the osmotic driving compartment, the first semi permeable membrane being exposed to the patient;
a second semi permeable membrane disposed in the open end of the osmotic driving compartment, and a first impermeable barrier disposed over the second semi permeable membrane, the second semi permeable membrane being sealed from the patient until the first barrier is breached, wherein breaching the first barrier increases the surface area of semi permeable membrane exposed to the patient and increases a delivery rate of a pharmaceutical agent through the delivery orifice. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)
a third semi permeable member, and a second impermeable barrier, the second impermeable barrier being disposed over the third semi permeable membrane, the third semi permeable membrane being sealed from the patient until the second impermeable barrier is breached, wherein breaching the second barrier increases the surface area of semi permeable membrane exposed to the patient and increases a delivery rate of the pharmaceutical agent through the delivery orifice.
-
-
9. The pump system of claim 8, further comprising a saturated solution including NaCl between the second barrier and the third semi permeable membrane.
-
10. The pump system of claim 1, wherein the pharmaceutical agent compartment contains sufentanil.
-
11. The pump system of claim 10, wherein the sufentanil is at a concentration selected between about 200 μ
- g/mL and about 15,000 μ
g/mL.
- g/mL and about 15,000 μ
-
12. The pump system of claim 1, wherein the delivery rate of the pharmaceutical agent through the delivery orifice is selected from about:
-
0.5 micrograms per day to about 25 micrograms per day when the pump is configured to deliver the pharmaceutical agent intraventricularly;
0.5 micrograms per day to about 50 micrograms per day when the pump is configured to deliver the pharmaceutical agent intrathecally;
5 micrograms per day to about 300 micrograms per day when the pump is configured to deliver the pharmaceutical agent epidurally, and 10 micrograms per day to about 300 micrograms per day when the pump is configured to deliver the pharmaceutical agent subcutaneously.
-
-
13. The pump system of claim 1, wherein the first and second semi permeable membranes include cellulose acetate.
-
14. The pump system of claim 1, wherein the first semi permeable membrane is shaped as a torus and is disposed adjacent an outer periphery of the first impermeable barrier and wherein the second semi permeable membrane is disposed in a center opening of the torus.
-
15. The pump system of claim 1, further comprising a catheter coupled to the delivery orifice.
-
16. The pump system of claim 15, wherein the catheter has an inner diameter of between about 0.001 inches and about 0.010 inches.
-
17. The pump system of claim 15, wherein the catheter includes a guidewire lumen and a pharmaceutical agent infusion lumen.
-
18. The pump system of claim 17, wherein the pharmaceutical agent infusion lumen has an inner diameter selected between about 0.001 inches to about 0.010 inches.
-
19. The pump system of claim 17, wherein the guidewire lumen includes a valve to prevent back flow of fluid into the guidewire lumen.
-
20. The pump system of claim 15, wherein the catheter and the pump are dimensioned to infuse a volume of pharmaceutical agent of between about 1 μ
- L/day and about 10 μ
L/day over a treatment period.
- L/day and about 10 μ
-
21. The pump system of claim 15, wherein the catheter and the pump are dimensioned to infuse a dose of pharmaceutical agent of between about 0.5 μ
- g/day and about 300 μ
g/day over a treatment period.
- g/day and about 300 μ
-
22. The pump system of claim 15, wherein at least a portion of the catheter is radiopaque.
-
23. An integrated implantable pump and catheter system for delivering a dose of pharmaceutical agent to a patient over a treatment period, comprising:
-
a pump housing;
a moveable partition disposed within the housing, the partition dividing the housing into an driving engine compartment and a pharmaceutical having an open end agent compartment having a delivery orifice;
a catheter coupled to the delivery orifice;
a preloaded amount of pharmaceutical agent in the pharmaceutical agent compartment, and a mechanical an infusion rate selection structure disposed within the open end configured to allow the infusion rate of the pump to be increased while the system is implanted in the patient, the infusion rate selection structure including a plurality of semi permeable membranes, wherein selectively exposing a surface area of the plurality of semipermeable membranes to the patient increases the infusion rate of the pharmaceutical agent. - View Dependent Claims (24, 25, 28, 29)
-
-
26. A method of delivering a pharmaceutical agent to a patient, comprising the steps of:
-
implanting an osmotic pump within the patient, the osmotic pump including a pump housing, a moveable partition disposed within the housing, the partition dividing the housing into a driving engine compartment having an open end and a pharmaceutical agent compartment, a preloaded amount of the pharmaceutical agent in the pharmaceutical agent compartment, and a mechanical infusion rate selection structure disposed within the open end configured to allow an infusion rate of the pump to be increased while the pump is implanted in the patient, the infusion rate selection structure including a plurality of semi-permeable membranes, and controlling a surface area of the plurality of the semi permeable membranes exposed to the patient to control and infusion rate of the pharmaceutical agent to the patient. - View Dependent Claims (27)
-
-
30. An implantable pump for delivering a dose of pharmaceutical agent to a patient over a treatment period, comprising:
-
a pump housing;
a moveable partition disposed within the housing, the partition dividing the housing into an driving engine compartment and a pharmaceutical agent compartment having a delivery orifice;
a preloaded amount of pharmaceutical agent in the pharmaceutical agent compartment, and a mechanical infusion rate selection structure configured to allow the infusion rate of the pump to be increased while the system is implanted in the patient, the infusion rate selection structure including a plurality of semi permeable membranes, wherein selectively exposing a surface area of the plurality of semipermeable membranes to the patient increases the infusion rate of the pharmaceutical agent. - View Dependent Claims (31, 32)
-
Specification